Clinical Trial Update: Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis [Phase 2]

View source ↗

Summary

Phase 2 trial comparing CRS-HIPEC using mitomycin-C vs. melphalan for colorectal peritoneal carcinomatosis (appendiceal/colorectal cancers).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Appendiceal Cancer
• Colorectal Cancer

Drugs mentioned

• Melphalan (Melphalan)
• Mitomycin-C (mitomycin C)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Cancer, Appendiceal, ColoRectal Cancer | Phase 2 | Status: UNKNOWN